HEIDELBERG starts the 2024/2025 financial year with a strong order volume from drupa
- Strong second half-year expected thanks to high order backlog
- As expected, sales and EBITDA down year-on-year in the first quarter due to reluctance to buy ahead of drupa
- Growth potential: cooperation with Canon for industrial digital printing in the commercial sector
- Annual forecast confirmed
Heidelberger Druckmaschinen AG (HEIDELBERG) has started the new financial year 2024/2025 with strong growth in incoming orders. Thanks to the highly successful drupa industry trade fair, the technology company's incoming orders in the first three months (April 1 to June 30, 2024) exceeded its own expectations of around € 650 million at € 701 million (previous year: € 591 million). The best order value since 2016 thus forms a strong basis for the entire financial year with a high order backlog of € 923 million (March 31: € 652 million). The regions of Europe (+25%) and the Americas (+30%) recorded particularly strong growth. Growth was only slightly weaker in Asia (+3%), as the previous year had been particularly strong due to the important industry trade fair Print China.
"The strong recovery in our order intake allows us to look to the full financial year with great confidence," said Jürgen Otto, CEO of HEIDELBERG. "The pleasing order backlog from the drupa trade fair will lead to rising sales in the following quarters compared to Q1. At the same time, we are working on our cost situation and personnel costs, which are generally too high."
Forecast confirmed despite after-effects of the order slump
As expected, sales in the first quarter of € 403 million were below the previous year's level (€ 544 million) due to the reluctance to invest ahead of drupa. The adjusted operating result (EBITDA) fell by around € 51 million to € –9 million compared to the adjusted figure for the same quarter of the previous year. The corresponding EBITDA margin was –2.3% (previous year: 7.7%). Net result after taxes fell to € –42 million (previous year: € 10 million). As expected, free cash flow was negative at € –103 million (previous year: € –27 million) due to the quarterly loss, the increase in inventories because of the high order intake and seasonal effects.
"HEIDELBERG felt the after-effects of the slump in orders from the third quarter of 2023/2024 in the first quarter," said Tania von der Goltz, CFO. "Despite the expected improvements in sales and earnings in the second half of the year, we will continue to work on our costs and efficiency. We expect to achieve the previous year's result in the current year."
In the Print Solutions segment in particular, HEIDELBERG recorded strong drupa-related growth in incoming orders of around 21 percent. In contrast, sales declined by around 23% from April to June due to the low order intake in the third quarter of the previous year. Incoming orders in the Packaging Solutions segment improved by 17 percent, while sales in this segment fell by 29 percent as expected.
HEIDELBERG presented itself at drupa as a total solution provider for the printing industry with offset and digital. In particular, the cooperation with Canon is intended to open up the growing market in digital industrial commercial printing. HEIDELBERG aims to significantly increase its sales in this area in the medium term.
The forecast for the 2024/2025 financial year is confirmed against the backdrop of the strong order intake. Assuming that the global economy does not grow more slowly than predicted by economic research institutes, HEIDELBERG expects stable earnings development with sales remaining the same.
Images and further information about the company are available on the Investor Relations and Press Portal of Heidelberger Druckmaschinen AG at www.heidelberg.com.
For further information:
Corporate Communications
Oliver Claas
Phone: +49 6222 82-67179
E-Mail: Oliver.Claas@heidelberg.com
Thomas Fichtl
Phone: +49 6222 82- 67123
E-Mail: Thomas.Fichtl@heidelberg.com
Investor Relations
Maximilian Beyer
Tel: +49 (0)6222 82-67120
E-Mail: Maximilian.Beyer@heidelberg.com
Important note:
This press release contains forward-looking statements based on assumptions and estimates made by the management of Heidelberger Druckmaschinen Aktiengesellschaft. Even if the company management is of the opinion that these assumptions and estimates are accurate, actual future developments and future actual results may deviate considerably from these assumptions and estimates due to a variety of factors. These factors may include, for example, changes in the overall economic situation, exchange rates and interest rates as well as changes within the graphic arts industry. Heidelberger Druckmaschinen Aktiengesellschaft provides no guarantee and assumes no liability that future developments and the actual results achieved in the future will correspond to the assumptions and estimates made in this press release.
Contacts
Heidelberger Druckmaschinen AG
P.O. Box 10 29 40
69019 Heidelberg
Germany
Kurfürsten-Anlage 52-60
69115 Heidelberg
Florian Pitzinger
Phone +49 (6222) 82 2553
Florian.Pitzinger@heidelberg.com
www.heidelberg.com
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships14.1.2025 13:05:41 CET | Press Release
Andernach – LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company, is proud to announces its selection as a Concept Stage winner for two projects in the #PatchForwardPrize, a $50 million challenge by the Biomedical Advanced Research and Development Authority (BARDA) to advance microneedle patch-based RNA vaccine technologies. The Patch Forward Prize, part of the Project NextGen initiative led by BARDA, aims to accelerate next-generation vaccine technologies. By fostering partnerships between vaccine developers and delivery platform innovators, the competition drives progress from concept to clinical stages, paving the way for transformative advancements in global health. Each of the prizes announced today represents an award of US$ 2 million, that will be shared between LTS and its partners. The awarded projects bring together LTS’s proprietary dissolvable Microneedle Array Patch (MAP) technology with mRNA vaccines from two partners, BioNet, a biotech man
FEV develops AI-supported driver monitoring system CogniSafe9.1.2025 11:00:00 CET | Pressmeddelande
Aachen – FEV, a leading global innovation driver for the mobility of tomorrow, presents CogniSafe, a state-of-the-art Driver Monitoring System (DMS) that significantly increases road safety. The system uses advanced technologies such as deep learning and computer vision to monitor driver conditions such as distraction, fatigue and inattention in real time and under even the most challenging conditions.
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer9.1.2025 10:25:56 CET | Press Release
Aachen, Germany, 09 January 2025 – Grünenthal announced today that Prof. Dr. Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the Corporate Executive Board, effective 01 February 2025. Uli Brödl has more than 15 years of industry experience. He joins Grünenthal from Boehringer Ingelheim, where he served as Corporate Senior Vice President, Head of Global Clinical Development & Operations, and member of Boehringer Ingelheim's Venture Fund Investment Committee. In his most recent role, he oversaw end-to-end clinical development and operations activities across therapeutic areas and worked at the interface of R&D, Commercial, and Market Access functions. He has a proven track record of bringing innovative medicines to patients, including Empagliflozin, an oral anti-diabetic medicine. Earlier in his career, Uli Brödl led Boehringer Ingelheim's Canadian medical organisation and gained extensive market experience. In parallel, he founded and co-chaired the BI Can
175 years of Heidelberger Druckmaschinen: Company starts anniversary year with growth strategy8.1.2025 13:11:11 CET | Press Release
Growth strategy: medium-term sales potential of more than € 300 million Growth drivers in the core business: packaging, digital printing Software and lifecycle business Industrial business: focus on further expansion 175 years: the company has been shaping the printing industry for decades with technological innovations, quality and reliability Numerous anniversary activities throughout the year
Assessing risks from pharmaceutical residues: How the APRIORA project is helping communities to improve drinking water quality7.1.2025 08:16:33 CET | Press Release
As part of the EU-funded APRIORA project, drug residues are being analysed. Scientists from the University of Rostock are taking water samples in all weathers. The aim is to use innovative approaches to improve wastewater treatment in Europe.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom